Feed 1672.HK
16
Ascletis Pharma Inc.
1672.HK · HKSE
$10.47 -2.24% (-$0.24)
1M +26.05%
Market Cap ¥9.7B
P/E Ratio -
Div. Yield -
ROE 17.57%
Valuation
19 /100
Expensive P/S 4,776.03x
P/B 5.01x
P/E N/A
Growth
0 /100
Declining Rev. growth 66.53%
Book val. growth 8.67%
EPS growth N/A
Profitability
9 /100
Weak Gross margin 25.99%
FCF margin 16,312.90%
Net margin 17,745.60%
Quality
0 /100
Poor ROIC 24.97%
Asset turnover 0.00x
ROE 17.57%
Debt
69 /100
Low Debt/Equity 0.00x
Int. coverage -2,954.46x
Current ratio 15.05x
Stability
12 /100
Unstable Beta 0.38x
Profitable years 0
Rev. volatility 79.17%
Vprašajte StockBota o 1672.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jinzi J. Wu
Employees
202
Headquarters
Hangzhou
Prihajajoči dogodki
31 AVG.
Earnings
Upcoming earnings report